He was among the first scientists in the late eighties to suggest that this dosage in the patient plasma allowed to safely rule out venous thromboembolism, which was demonstrated in subsequent publications of the Geneva research group.
[4][5] He was among the first scientists in the late eighties to suggest that this dosage in the patient plasma allowed to safely rule out venous thromboembolism, which was demonstrated in the subsequent publications of the Geneva research group.
[6] Henri Bounameaux completed his primary and secondary education at Lubumbashi (Belgian Congo, Zaïre) and Baccalaureate type C from St.-Louis, France in 1971.
Professor Bounameaux research interests are broad and include studies on Non-invasive vascular diagnosis, venous thromboembolism and pulmonary embolism & Cardiology, Angiology, Hemostasis.
He was among the first scientists in the late eighties to suggest that this dosage in the patient plasma allowed to safely rule out venous thromboembolism, which was demonstrated in subsequent publications of the Geneva research group.